Tyra Biosciences, Inc.
TYRA
$36.22
$0.220.61%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -32.31% | -24.37% | -50.24% | -54.72% | -12.01% |
| Total Depreciation and Amortization | -8.33% | 3.15% | 11.11% | 17.21% | 41.18% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 35.91% | 19.94% | 122.96% | 92.52% | 87.78% |
| Change in Net Operating Assets | 710.38% | 765.22% | -124.14% | 56.02% | -94.92% |
| Cash from Operations | -20.59% | -25.04% | -130.84% | -15.57% | -44.77% |
| Capital Expenditure | -850.00% | 25.00% | 93.40% | 89.71% | 99.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 394.46% | -168.34% | 114.46% | 75.96% | 104.84% |
| Cash from Investing | 394.06% | -168.68% | 114.39% | 77.20% | 104.82% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 563.31% | -12.92% | -6.57% | -98.91% | 117.90% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 563.31% | -12.92% | 56.30% | -98.91% | 117.90% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 229.43% | -930.05% | 98.56% | -95.54% | 92.43% |